Weekday 1 is working with a biotech and pharma research team to pilot expert human-evaluation work. You will create and critique rubrics analyzing commercial drugs and development programs, assessing mechanism, clinical data, competitive position, and value drivers.
The role requires a US-based biotech investment analyst with a specialist-fund background and 5+ years evaluating biotech assets. The pilot spans 10–20 hours over 1–2 weeks and is remote, with potential to continue as the engagement
#J-18808-LjbffrBiotech Investment Analyst Remote Expert Evaluation Pilot in workfromhome at Unknown Company
This position is listed as full time and able to be worked remotely.